Application 063165
- Type
- ANDA
- Sponsor
- PHARMACIA AND UPJOHN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ADRIAMYCIN PFS | DOXORUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | 2MG/ML | No | No |
| 002 | ADRIAMYCIN PFS | DOXORUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | 200MG/100ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A063165-001 | ADRIAMYCIN PFS | DOXORUBICIN HYDROCHLORIDE | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | ||
| A063165-002 | ADRIAMYCIN PFS | DOXORUBICIN HYDROCHLORIDE | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A063165-001 | ADRIAMYCIN PFS | 2MG/ML | INJECTABLE / INJECTION | 1991-01-30 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A063165-002 | ADRIAMYCIN PFS | 200MG/100ML | INJECTABLE / INJECTION | 1991-01-30 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | 55889588-c5f1-d9bc-e063-6294a90a5791 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | f6508535-e7a7-4e50-8d0c-43deda8d0d08 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | 1fd148fb-0fbc-4b6f-b790-23546fb46a71 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | 00634b2b-4e48-4178-8877-28582af894ad | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | NorthStar RxLLC | ddf55319-bf62-4ec7-8be2-ef97188837c4 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | fbc48fa5-0bfb-4957-b13c-a56bb7a13b56 | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | ada390ce-50ea-4de5-be58-5b03caf33c23 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | Dr. Reddy's Laboratories Inc. | 0885dddf-727e-4692-92dd-a26c69cc278d | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 15a84bd6-b565-4722-bb92-e4c919620a90 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| DOXIL | DOXORUBICIN HYDROCHLORIDE | Baxter Healthcare Corporation | 917eddf9-1d3f-4abe-8c81-d33b066e5bae | 2026-03-10 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride Liposome | DOXORUBICIN HYDROCHLORIDE | Sagent Pharmaceuticals | c8eb4784-36e0-483f-9e5d-af0552e49bb5 | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 0f8eb9a1-74d0-47fd-94b8-a65b29006521 | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | Sagent Pharmaceuticals | ae80bd3a-b99a-4e01-a444-b9d05687f00e | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | Alembic Pharmaceuticals Limited | f8e001f5-441c-47cd-86f6-5d5e3de16bc0 | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Pfizer Laboratories Div Pfizer Inc | d31d7f58-66d0-4826-b6b5-5914c031965f | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | BluePoint Laboratories | b8b66e93-0813-4876-b291-8d7c36a99807 | 2024-12-11 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Fresenius Kabi USA, LLC | e0349f98-42fa-4003-b6d8-a1db1401b0ef | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | Gland Pharma Limited | 74b14803-afc8-4a2e-ba92-43f1a72025eb | 2024-09-24 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | Actavis Pharma, Inc. | 33ddfdb1-b4bc-464d-a186-49c4b156279f | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
| Doxorubicin Hydrochloride | DOXORUBICIN | Amneal Pharmaceuticals LLC | d928625e-c1ef-4f25-8d25-764c8c6aab67 | 2024-05-29 | Boxed warning, Warnings, Adverse reactions | DOXORUBICIN HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.